David C. Rayner

5.3k total citations
43 papers, 1.7k citations indexed

About

David C. Rayner is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, David C. Rayner has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in David C. Rayner's work include Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (10 papers) and Renal Transplantation Outcomes and Treatments (6 papers). David C. Rayner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (10 papers) and Renal Transplantation Outcomes and Treatments (6 papers). David C. Rayner collaborates with scholars based in Canada, United States and United Kingdom. David C. Rayner's co-authors include Philip F. Halloran, Anette Melk, Bernhard M. W. Schmidt, Attapong Vongwiwatana, Oki Takeuchi, Birgit Sawitzki, Brian Champion, Anne Cooke, Lin Zhu and I M Roitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

David C. Rayner

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Rayner Canada 20 419 371 340 333 203 43 1.7k
Kensuke Ohta Japan 25 676 1.6× 492 1.3× 301 0.9× 219 0.7× 136 0.7× 104 2.7k
Karen Hamilton United States 18 609 1.5× 465 1.3× 698 2.1× 201 0.6× 105 0.5× 37 2.5k
Štefan Porubský Germany 30 722 1.7× 299 0.8× 768 2.3× 181 0.5× 314 1.5× 92 2.3k
Ryuji Ohashi Japan 21 684 1.6× 427 1.2× 249 0.7× 120 0.4× 423 2.1× 119 1.8k
Agnieszka Hałoń Poland 26 606 1.4× 530 1.4× 369 1.1× 75 0.2× 110 0.5× 183 2.2k
Beom Jin Lim South Korea 29 582 1.4× 465 1.3× 470 1.4× 128 0.4× 970 4.8× 163 2.8k
Guadalupe Ortiz-Muñoz Spain 20 518 1.2× 294 0.8× 759 2.2× 150 0.5× 128 0.6× 23 2.1k
Helen Feiner United States 32 825 2.0× 410 1.1× 178 0.5× 349 1.0× 712 3.5× 80 3.0k
Jason S. Koh United States 20 713 1.7× 232 0.6× 582 1.7× 163 0.5× 285 1.4× 27 1.8k
Nelli Shushakova Germany 26 481 1.1× 212 0.6× 409 1.2× 77 0.2× 354 1.7× 50 1.5k

Countries citing papers authored by David C. Rayner

Since Specialization
Citations

This map shows the geographic impact of David C. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Rayner more than expected).

Fields of papers citing papers by David C. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Rayner. The network helps show where David C. Rayner may publish in the future.

Co-authorship network of co-authors of David C. Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Rayner. A scholar is included among the top collaborators of David C. Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Rayner. David C. Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haddad, George, Lin Zhu, David C. Rayner, & Allan G. Murray. (2013). Experimental Glomerular Endothelial Injury In Vivo. PLoS ONE. 8(10). e78244–e78244. 4 indexed citations
2.
Bigam, David L., et al.. (2013). A comparison of combination dopamine and epinephrine treatment with high-dose dopamine alone in asphyxiated newborn piglets after resuscitation. Pediatric Research. 73(1-4). 435–442. 11 indexed citations
3.
Sis, B., Kim Solez, & David C. Rayner. (2009). The Case ∣ A kidney transplant presenting with acute renal failure and mass. Kidney International. 75(5). 565–566. 1 indexed citations
4.
Melk, Anette, Bernhard M. W. Schmidt, Attapong Vongwiwatana, et al.. (2008). Effects of Donor Age and Cell Senescence on Kidney Allograft Survival. American Journal of Transplantation. 9(1). 114–123. 84 indexed citations
5.
Rayner, David C., et al.. (2007). Real-time heuristic search with a priority queue. International Joint Conference on Artificial Intelligence. 2372–2377. 22 indexed citations
6.
Vongwiwatana, Attapong, Adis Tasanarong, David C. Rayner, Anette Melk, & Philip F. Halloran. (2005). Epithelial to Mesenchymal Transition During Late Deterioration of Human Kidney Transplants: The Role of Tubular Cells in Fibrogenesis. American Journal of Transplantation. 5(6). 1367–1374. 150 indexed citations
7.
Melk, Anette, Elaine Mansfield, Szu‐Chuan Hsieh, et al.. (2005). Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling. Kidney International. 68(6). 2667–2679. 83 indexed citations
8.
Koufogiannakis, Denise, Jeanette Buckingham, Arif Alibhai, & David C. Rayner. (2005). Impact of librarians in first‐year medical and dental student problem‐based learning (PBL) groups: a controlled study. Health Information & Libraries Journal. 22(3). 189–195. 35 indexed citations
9.
Melk, Anette, Bernhard M. W. Schmidt, Attapong Vongwiwatana, David C. Rayner, & Philip F. Halloran. (2005). Increased Expression of Senescence-Associated Cell Cycle Inhibitor p16 in Deteriorating Renal Transplants and Diseased Native Kidney. American Journal of Transplantation. 5(6). 1375–1382. 126 indexed citations
10.
11.
Melk, Anette, Bernhard M. W. Schmidt, Oki Takeuchi, et al.. (2004). Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney International. 65(2). 510–520. 270 indexed citations
12.
Elliott, John F., Junliang Liu, Kunimasa Suzuki, et al.. (2003). Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice. Proceedings of the National Academy of Sciences. 100(23). 13447–13452. 63 indexed citations
13.
Bléoo, Stacey, Roseline Godbout, David C. Rayner, Yahya Tamimi, & Ronald B. Moore. (2003). Leiomyosarcoma of the Bladder in a Retinoblastoma Patient. Urologia Internationalis. 71(1). 118–121. 11 indexed citations
14.
15.
Moore, Ronald B., et al.. (2001). Light dosimetry using the P3 approximation.. Physics in Medicine and Biology. 46(9). 2359–2370. 23 indexed citations
16.
Melk, Anette, Vido Ramassar, Lisa M. H. Helms, et al.. (2000). Telomere Shortening in Kidneys with Age. Journal of the American Society of Nephrology. 11(3). 444–453. 151 indexed citations
17.
Trpkov, Kiril, Niels Marcussen, David C. Rayner, George Lam, & Kim Solez. (1997). Kidney allograft with a lymphocytic infiltrate: Acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?. American Journal of Kidney Diseases. 30(3). 449–454. 21 indexed citations
18.
Champion, Brian, Anne Cooke, & David C. Rayner. (1992). Thyroid autoimmunity. Current Opinion in Immunology. 4(6). 770–778. 17 indexed citations
19.
Champion, Brian, Kevin Page, Nicole M. Parish, et al.. (1991). Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells.. The Journal of Experimental Medicine. 174(2). 363–370. 85 indexed citations
20.
Champion, Brian, Patricia Hutchings, David C. Rayner, et al.. (1991). In vitro regulation of thyroglobulin (Tg) autoantibody production by Tg-specific T-cell lines and hybridomas.. PubMed. 73(4). 415–20. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kensuke Ohta Breakdown of academic impact, for papers by Karen Hamilton Breakdown of academic impact, for papers by Štefan Porubský Breakdown of academic impact, for papers by Ryuji Ohashi Breakdown of academic impact, for papers by Agnieszka Hałoń Breakdown of academic impact, for papers by Beom Jin Lim Breakdown of academic impact, for papers by Guadalupe Ortiz-Muñoz Breakdown of academic impact, for papers by Helen Feiner Breakdown of academic impact, for papers by Jason S. Koh Breakdown of academic impact, for papers by Nelli Shushakova
Rankless by CCL
2026